Unilever faces £14bn hurdle to sweeten Glaxo bid

Analysts question the strategic and financial reasoning behind £50bn offer for Glaxo's consumer healthcare division

The Telegraph | Dirección | Gestión de Empresas |

Leer noticia completa en el medio original
Spanish